Sign In
to Vote &
Create Storyboards.
 
Four Biotech Stocks Analysts Think Will Triple In Price In running this screen for this first week of September, the following four stocks have hit our radar as high potential, deep value candidates. These stocks have an average analyst price target that is at least 200% higher than its current share price.
5
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard